On October 25, 2023, Tammy Reilly notified Sorrento Therapeutics, Inc. that she was resigning from the Board of Directors of the Company, effective immediately. Ms. Reilly informed the Company that her resignation was due to concerns regarding the Company's Chief Restructuring Officer's continued lack of communication with the Board on decisions made and the general operating of the Company and changes in the Company's directors' and officers' insurance policy without Board input.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0113 USD | -22.07% | +7.62% | -90.85% |
Apr. 10 | Sorrento Therapeutics, Inc. Emerged from Bankruptcy | CI |
Mar. 15 | Scilex Settles Claims in Case Against Virpax for $6 Million, 6% Royalties From Three Drugs | MT |
1st Jan change | Capi. | |
---|---|---|
-90.85% | 6.14M | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- SRNE Stock
- News Sorrento Therapeutics, Inc.
- Sorrento Therapeutics, Inc. Announces Resignation of Tammy Reilly from the Board of Directors